PRESS RELEASE
News
-
-
PRESS RELEASE
GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
GENFIT receives positive opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis, awaiting final European Commission decision. Details in press release -
-
-
-
-
-
-
PRESS RELEASE
GENFIT : Les nouvelles recommandations de pratique clinique de l'EASL-EASD-EASO pour la MASLD incluent NIS2+® comme outil-clé pour la détection de la MASH à risque
Les nouvelles recommandations de l'EASL-EASD-EASO incluent NIS2+® comme outil-clé pour la détection de la MASH à risque. GENFIT annonce son rôle dans l'identification des patients pour les traitements émergents de la MASH -
PRESS RELEASE
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
GENFIT announces inclusion of NIS2+® in new EASL-EASD-EASO Clinical Practice Guidelines for MASLD, as a key tool for detecting at-risk MASH. Guidelines provide update on prevention, screening, diagnosis, follow-up, and treatment for MASLD
